Literature DB >> 528055

Use of antibodies to purified Newcastle disease virus glycoproteins for strain comparisons and characterizations.

R J Avery, J Niven.   

Abstract

The H/N and F1 glycoproteins responsible for hemagglutinin/neuraminidase (H/N) activity and fusion (F1) activity were purified from several Newcastle disease virus strains and used to produce antisera. These antisera can be used to clearly distinguish the virus strains by a number of techniques including radioimmunoassay, and so provide a means of classifying new virus isolates. The variations detected between strains are not related to field virulence.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528055      PMCID: PMC414688          DOI: 10.1128/iai.26.3.795-801.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Studies on mixed infection with Newcastle disease virus. I. Isolation of Newcastle disease virus mutants and tests for genetic recombination between them.

Authors:  A GRANOFF
Journal:  Virology       Date:  1959-12       Impact factor: 3.616

2.  Identification of vaccine strains of Newcastle disease virus.

Authors:  R P HANSON; C A BRANDLY
Journal:  Science       Date:  1955-07-22       Impact factor: 47.728

3.  Strain differences in the Newcastle disease virus.

Authors:  L W MACPHERSON; R H SWAIN
Journal:  J Hyg (Lond)       Date:  1956-06

4.  Antigenic differences among strains of Newcastle disease virus.

Authors:  E UPTON; R P HANSON; C A BRANDLY
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

5.  Inactivation of Newcastle disease virus by beta-propiolactone.

Authors:  B Garlick; R J Avery
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  Structural components of Sendai virus. Serological and physicochemical characterization of hemagglutinin subunit associated with neuraminidase activity.

Authors:  H Tozawa; M Watanabe; N Ishida
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

7.  Parainfluenza virus surface projections: glycoproteins with haemagglutinin and neuraminidase activities.

Authors:  C Chen; R W Compans; P W Choppin
Journal:  J Gen Virol       Date:  1971-04       Impact factor: 3.891

8.  Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein.

Authors:  A Scheid; L A Caliguiri; R W Compans; P W Choppin
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

9.  Immunologic properties of purified Sendai virus glycoproteins.

Authors:  C Orvell; E Norrby
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

10.  Antigenic differences between strains of Newcastle disease virus.

Authors:  T H Pennington
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

View more
  8 in total

1.  Antigenic relationships between avian paramyxoviruses. I. Quantitative characteristics based on hemagglutination and neuraminidase inhibition tests.

Authors:  M Lipkind; E Shihmanter
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.

Authors:  P H Russell
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Biological functions of monospecific antibodies to envelope glycoproteins of Newcastle disease virus.

Authors:  Y Umino; T Kohama; M Kohase; A Sugiura; H D Klenk; R Rott
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

4.  Interaction of Newcastle disease virus strains differing in virulence with chicken red blood cell receptors.

Authors:  B Rivetz; M Lipkind
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Newcastle disease virus fusion protein expressed in a fowlpox virus recombinant confers protection in chickens.

Authors:  J Taylor; C Edbauer; A Rey-Senelonge; J F Bouquet; E Norton; S Goebel; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Separation of Sendai virus glycoproteins by using glutaraldehyde-treated erythrocytes and preparation of monospecific antisera against the glycoproteins.

Authors:  Y Hosaka
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge.

Authors:  J Taylor; S Pincus; J Tartaglia; C Richardson; G Alkhatib; D Briedis; M Appel; E Norton; E Paoletti
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Revertant analysis of a temperature-sensitive mutant of Newcastle disease virus with defective glycoproteins: implication of the fusion glycoprotein in cell killing and isolation of a neuraminidase-deficient hemagglutinating virus.

Authors:  G W Smith; L E Hightower
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.